305 related articles for article (PubMed ID: 6832622)
1. Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
Lind T; Cederberg C; Ekenved G; Haglund U; Olbe L
Gut; 1983 Apr; 24(4):270-6. PubMed ID: 6832622
[TBL] [Abstract][Full Text] [Related]
2. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
Howden CW; Forrest JA; Reid JL
Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
[TBL] [Abstract][Full Text] [Related]
3. Acid inhibitory characteristics of omeprazole in man.
Cederberg C; Ekenved G; Lind T; Olbe L
Scand J Gastroenterol Suppl; 1985; 108():105-12. PubMed ID: 3858972
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.
Wilson JA; Boyd EJ; Wormsley KG
Dig Dis Sci; 1984 Sep; 29(9):797-801. PubMed ID: 6432499
[TBL] [Abstract][Full Text] [Related]
5. [Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].
Müller P; Seitz HK; Simon B; Dammann HG
Arzneimittelforschung; 1983; 33(12):1685-6. PubMed ID: 6686775
[TBL] [Abstract][Full Text] [Related]
6. Effect of omeprazole on gastric acid secretion in man.
Olbe L; Lind T; Cederberg C; Ekenved G
Scand J Gastroenterol Suppl; 1986; 118():105-7. PubMed ID: 3460164
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole, a long-lasting inhibitor of gastric secretion.
Larson GM; Sullivan HW
J Surg Res; 1984 May; 36(5):503-7. PubMed ID: 6727328
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
[TBL] [Abstract][Full Text] [Related]
9. Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man.
Jansen JB; Lundborg P; Baak LC; Greve J; Ohman M; Stöver C; Röhss K; Lamers CB
Gut; 1988 Jan; 29(1):75-80. PubMed ID: 3343017
[TBL] [Abstract][Full Text] [Related]
10. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
11. Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily.
Thompson JN; Barr JA; Collier N; Spencer J; Bush A; Cope L; Gribble RJ; Baron JH
Gut; 1985 Oct; 26(10):1018-24. PubMed ID: 3932137
[TBL] [Abstract][Full Text] [Related]
12. [Behavior of acid secretion under the long-term daily administration of omeprazol].
Dammann HG; Müller P; Seitz HK; Simon B
Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940
[TBL] [Abstract][Full Text] [Related]
13. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs.
De Graef J; Woussen-Colle MC
Gastroenterology; 1986 Aug; 91(2):333-7. PubMed ID: 2873074
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole-induced hypergastrinemia: role of gastric acidity.
Larson GM; Sullivan HW; Rayford P
J Surg Res; 1986 May; 40(5):504-9. PubMed ID: 3736035
[TBL] [Abstract][Full Text] [Related]
15. Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo.
Larsson H; Mattson H; Sundell G; Carlsson E
Scand J Gastroenterol Suppl; 1985; 108():23-35. PubMed ID: 3858975
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study.
Pisegna JR; Martin P; McKeand W; Ohning G; Walsh JH; Paul J
Am J Gastroenterol; 1999 Oct; 94(10):2874-80. PubMed ID: 10520836
[TBL] [Abstract][Full Text] [Related]
17. Single intravenous administration of the H+, K(+)-ATPase inhibitor BY 1023/SK&F 96022--inhibition of pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Simon B; Müller P; Bliesath H; Lühmann R; Hartmann M; Huber R; Wurst W
Aliment Pharmacol Ther; 1990 Jun; 4(3):239-45. PubMed ID: 1966542
[TBL] [Abstract][Full Text] [Related]
18. Rabeprazole is superior to omeprazole for the inhibition of peptone meal-stimulated gastric acid secretion in Helicobacter pylori-negative subjects.
Ohning GV; Walsh JH; Pisegna JR; Murthy A; Barth J; Kovacs TO
Aliment Pharmacol Ther; 2003 May; 17(9):1109-14. PubMed ID: 12752347
[TBL] [Abstract][Full Text] [Related]
19. Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Simon B; Müller P; Marinis E; Lühmann R; Huber R; Hartmann R; Wurst W
Aliment Pharmacol Ther; 1990 Aug; 4(4):373-9. PubMed ID: 2151747
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
